Relationship of "prodromal" symptoms with severity and type of psychopathology in the active phase of schizophrenia

Comprehensive Psychiatry

Volumn 51, Issue 1, 2010, Pages 1-7

  Moukas, George ^a   Stathopoulou, Anastasia ^a   Gourzis, Philippos ^a   Beratis, Ion N ^a   Beratis, Stavroula ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DISORIENTATION; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PARANOIA; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; SCHIZOPHRENIA; SYMPTOM;

ADOLESCENT; ADULT; AGE OF ONSET; ANALYSIS OF VARIANCE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REGRESSION ANALYSIS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 70449627881     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.comppsych.2009.02.001     Document Type: Article

References (40)

1. Robinson D., Woerner M.G., Alvir J.M., Bilder R., Goldman R., Geisler S., et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 56 (1999) 241-247
2. Robinson D.G., Woerner M.G., McMeniman M., Mendelowitz A., and Bilder R.M. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 161 (2004) 473-479
3. Morrison A.P., French P., Parker S., Roberts M., Stevens H., Bentall R.P., et al. Three year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr Bull 33 (2007) 682-687
4. Cannon T.D., Huttunen M.O., Dahlström M., Larmo I., Räsänen P., and Juriloo A. Antipsychotic drug treatment in the prodromal phase of schizophrenia. Am J Psychiatry 159 (2002) 1230-1232
5. McGorry P.D., Young A.R., Phillips L.J., Yuen H.P., Francey S., and Cosgrave E.M. Randomized controlled trial of interventions designed to reduce the risk of progression to first episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 59 (2002) 921-928
6. Woods S.W., Breier A., Zipurski R.B., Perkins D.O., Addington J., Miller T.J., et al. Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biol Psychiatry 54 (2003) 453-464
7. McGlashan T.H., Zipurski R.B., Perkins D., Addington J., Miller T., Woods S.W., et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 163 (2006) 790-799
8. Jackson H.J., McGorry P.D., and Dudgeon P. Prodromal symptoms of schizophrenia in first-episode psychosis: prevalence and specificity. Compr Psychiatry 36 (1995) 241-250
9. Keith S.J., and Matthews S.M. The diagnosis of schizophrenia: a review of onset and duration issues. Schizophr Bull 17 (1991) 51-67
10. Young A.R., McGorry P.D., McFarlane C.A., Jackson H.J., Patton G.C., and Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull 22 (1996) 283-303
11. Keshavan M.S., and Schooler N.R. First-episode studies in schizophrenia: criteria and characterization. Schizophr Bull 18 (1992) 491-513
12. Häfner H., Riecker-Rössler A., Maurer K., Fätkenheuer B., and Löffler W. First onset and early symptomatology of schizophrenia. A chapter of epidemiological and neurobiological research into age and sex differences. Eur Arch Psychiatry Clin Neurosci 242 (1992) 109-118
13. Häfner H., Maurer K., Löffler W., and Riecher-Rössler A. The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry 162 (1993) 80-86
14. Green M.F., Marshall Jr. B.D., Wirshing W.C., Ames D., Marder S.R., McGurk S., et al. Does risperidone improve verbal working memory in treatment-resistant schizophrenia?. Am J Psychiatry 154 (1997) 799-804
15. Cornblatt B.A., Lencz T., Smith C.W., Correll C.U., Auther A.M., and Nakayama E. The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr Bull 29 (2003) 633-651
16. Malla A., and Payne J. First-episode psychosis: psychopathology, quality of life, and functional outcome. Schizophr Bull 31 (2005) 650-671
17. Correll C.U., Penzner J.B., Frederickson A.M., Richter J.J., Auther A.M., Smith C.W., et al. Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome. Schizophr Bull 33 (2007) 703-714
18. Gourzis P., Katrivanou A., and Beratis S. Symptomatology of the initial prodromal phase of schizophrenia. Schizophr Bull 28 (2002) 415-429
19. American Psychiatric Association. DSM-IV-TR: diagnostic and statistical manual of mental disorders. 4th ed. (2000), American Psychiatric Association, Washington DC text revision
20. Auther A.M., Lencz T., Smith C.W., Bowie C.R., and Cornblatt B.A. Overview of the first annual workshop on the schizophrenia prodrome. Schizophr Bull 29 (2003) 625-631
21. Cannon T.D., Cornblatt B., and McGorry P. Editor's introduction: the empirical status of the ultra high risk (prodromal) research paradigm. Schizophr Bull 33 (2007) 661-664
22. Haroun N., Dunn L., Haroun A., and Cadenhead K.S. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull 32 (2006) 166-178
23. Young A.R., Stanford C., Cosgrave E., Killackey E., Phillips L., Nelson B., et al. Testing the ultra high risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr Bull 84 (2006) 57-66
24. Young A.R., Phillips L.J., McGorry P.D., McFarlane C.A., Francey S., Harrigan S., et al. Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br J Psychiatry Suppl 172 (1998) 14-20
25. Klosterkötter J., Hellmich M., Steinmeyer E.M., and Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 58 (2001) 158-164
26. Miller T.J., McGlashan T.H., Rosen J.L., Somjee L., Markovich P.J., Stein K., et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry 159 (2002) 863-865
27. Yung A.R., Phillips L.J., Yuen H.P., Francey S., McFarlane C.A., Halgren M., et al. Psychosis prediction: 12-month follow-up of a high-risk ("prodromal") group. Schizophr Res 60 (2003) 21-32
28. Meyer S.E., Bearden C.E., Lux S.R., Gordon J.L., Johnson J.K., O'Brien M.P., et al. The psychosis prodrome in adolescent patients viewed through the lens of DSM-IV. J Child Adolesc Psychopharmacol 15 (2005) 434-451
29. Lencz T., Smith C.W., McLaughlin D., Auther A., Nakayama E., Hovey L., et al. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol Psychiatry 59 (2006) 863-871
30. Heaton R.K., Gladsjo J.A., Palmer B.W., Kuck J., Marcotte T.D., and Jeste D.V. Stability and course of neuropsychological deficits in schizophrenia. Arc Gen Psychiatry 58 (2001) 24-32
31. Cannon T.D., and Mednick S.A. The schizophrenia high risk project in Copenhagen: three decades of progress. Acta Psychiatr Scand Suppl 370 (1993) 33-47
32. Cornblatt B., Obuchowski M., Roberts S., Pollack S., and Erlenmeyer-Kimling L. Cognitive and behavioral precursors of schizophrenia. Dev Psychopathol 11 (1999) 487-508
33. Erlenmeyer-Kimling L., Rock D., Roberts S.A., Janal M., Kestenbaum C., Cornblatt B., et al. Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. Am J Psychiatry 157 (2000) 1416-1422
34. Keefe R.S.E., Perkins D.O., Gu H., Zipursky R.B., Christensen B.K., and Liebermann J.A. A longitudinal study of neurocognitive function in individuals at-risk for psychosis. Schizophr Res 88 (2006) 26-35
35. First M.D., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured clinical interview for DSM-IV axis I disorders-patient edition (SCID I/P), version 2.0 (1995), Biometrics Research Department, New York State Psychiatric Institute, New York
36. Key S.R., Fiszbein A., and Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13 (1987) 261-276
37. Lykouras E., Botsis A., and Oulis P. The Positive and Negative Syndrome Scale (PANSS) (1994), Tsiveriotis, Athens, Greece [in Greek]
38. Gruenberg A.M., Kendler K.S., and Tsuang M.T. Reliability and concordance in the subtyping of schizophrenia. Am J Psychiatry 142 (1985) 1355-1358
39. Beratis S., Katrivanou A., and Gourzis P. Factors affecting smoking in schizophrenia. Compr Psychiatry 42 (2001) 393-402
40. Kendler K.S., Gruenberg A.M., and Tsuang M.T. Subtype stability in schizophrenia. Am J Psychiatry 142 (1985) 827-832